| TQVAX | VIVAX | TQVAX / VIVAX | |
| Total Expense Ratio | 0.99 | 0.17 | 582% |
| Annual Report Gross Expense Ratio | 2.31 | 0.17 | 1,359% |
| Fund Existence | 10 years | 34 years | - |
| Gain YTD | 22.228 | 18.503 | 120% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 93.5M | 256B | 0% |
| Annual Yield % from dividends | 1.05 | 1.74 | 61% |
| Returns for 1 year | 25.96 | 25.13 | 103% |
| Returns for 3 years | 50.44 | 60.56 | 83% |
| Returns for 5 years | 50.64 | 61.65 | 82% |
| Returns for 10 years | 128.40 | 157.71 | 81% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MAILX | 24.97 | 0.28 | +1.13% |
| BlackRock International Instl | |||
| HWLZX | 52.50 | 0.49 | +0.94% |
| Hotchkis & Wiley Large Cap Fdml Value Z | |||
| PHPSX | 40.67 | 0.37 | +0.92% |
| ProFunds Pharmaceuticals UltraSector Svc | |||
| JVMSX | 31.97 | 0.22 | +0.69% |
| JHancock Disciplined Value Mid Cap R2 | |||
| PSCHX | 27.55 | 0.15 | +0.55% |
| PGIM Jennison Small Company R2 | |||